Inventor · disambiguated record
Laura Sepp-Lorenzino
Also filed as: SEPP-LORENZINO LAURA
13 granted patents·6 pending applications·163 citations·filing 1998–2025
89Inventor score
Top patents by PatentIndex Score
19 records- 0190US10513703B2Hepatitis B virus (HBV) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Dec 24, 2019·6 cites·24 claims
- 0289US11060091B2Hepatitis B virus (HBV) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·2 cites·45 claims
- 0389US6670348B1Methods and compositions for destruction of selected proteinsSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 30, 2003·85 cites·40 claims
- 0487US10729787B2Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·2 cites·12 claims
- 0584US6989383B1Method of treating cancerSLOAN KETTERING INST CANCER·Filed 1998·Granted Jan 24, 2006·63 cites·14 claims
- 0679US2023144623A1Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0777US10933081B2Myostatin iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Mar 2, 2021·1 cites·20 claims
- 0876US10004814B2Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 26, 2018·2 cites·14 claims
- 0972US11529428B2Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·16 claims
- 1072US2025312490A1Systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moietySIRNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1167US2020291405A1HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1266US10640770B2Hepatitis D virus (HDV) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·0 cites·24 claims
- 1359US7238682B1Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinasesSLOAN KETTERING INST CANCER·Filed 2000·Granted Jul 3, 2007·2 cites·29 claims
- 1458US2010113577A1Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancerSHI BIN·Filed 2008·Application pending·0 cites
- 1546US2005137207A1Method of treating cancerFiled 2005·Application pending·0 cites
- 1642US2017304459A1Methods and compositions for inhalation delivery of conjugated oligonucleotideALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1739US11324820B2Methods for the treatment of subjects having a hepatitis b virus (HBV) infectionALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted May 10, 2022·0 cites·34 claims
- 1838US7271160B2Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinasesSLOAN KETTERING INST CANCER·Filed 2001·Granted Sep 18, 2007·0 cites·32 claims
- 1936US6482851B1Synthesis of dysidiolide and uses thereofSLOAN KETTERING INST CANCER·Filed 2000·Granted Nov 19, 2002·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Laura Sepp-Lorenzino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →